E

Elicio Therapeutics

35 employees

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Medical
Pharmaceutical

Date founded

2011

Funding rounds raised

Total raised

$33M

from 6 investors over 6 rounds

E

Elicio Therapeutics raised $10M on January 17, 2023

Investors: -

E

Elicio Therapeutics raised $2.8M on November 3, 2022

Investors: Gastro-Intestinal Research Foundation

E

Elicio Therapeutics raised $33M on October 2, 2019

Investors: Clal Biotechnology Industries, Livzon and Efung Capital

E

Elicio Therapeutics raised undisclosed on November 6, 2018

Investors: Thynk Capital

FAQ